- Pressemitteilung BoxID 349601
EUROFORUM Deutschland SE: Pharmaceutical sector: Fresh business ideas instead of outdated concepts
1st International Euroforum Summit "Rethinking Pharma" / 8 and 9 November 2012, Berlin / Programme: http://bit.ly/pharmasummitpr
The epicentre has shifted: patients have assumed an active role
While up to now, the pharmaceutical sector existed with the purpose of developing innovative medicines and distributing them in the largest quantities possible, manufacturers are now evolving into solution providers, observes Patrick Flochel, Head of Global Pharmaceuticals at Ernst & Young. "In the future, their role will increasingly be to comprehensively improve the health of patients and then to document and verify the results," says Flochel in a press release. In addition to the two main traditional places for health care provision - hospitals and doctor's practices - there now comes a third: the patient themselves. At the Pharma Summit, Flochel will discuss why this change not only represents a challenge for pharmaceutical manufacturers but also promises growth and value creation. The approach of moving the patient into the centre of future developments will also be examined by Charles Gore, President of the World Hepatitis Alliance, Christophe Bourdon, General Manager Central & Eastern Europe at Amgen and Dr Tobias Gantner, Head of Market Access at Bayer HealthCare. Joss Hertle from Google Germany will show how customers and patients can be reached via digital services and how media synergies and mobile trends can promote pharmaceutical marketing.
Impetus from the Mayo Clinic
Understanding patients so that you can also offer them the right treatment - this is also the goal of the renowned Mayo Clinic in the US. In the clinic's own think tank, the so-called "Center for Innovation" (CFI), researchers under the direction of Barbara Spurrier develop new ideas and processes for the health care sector. As part of their first appearance in Germany at the summit in Berlin, Spurrier will present their work and show what pharmaceutical companies can learn from the research activities at the CFI.
Ideas for successful research and development
It is also worth taking a closer look at the US pharmaceutical services company Covance. The company lays claim to being the second-largest biopharmaceutical research and development company in the world and posts yearly sales of over two billion US dollars. Covance recently increased its cooperation with Bayer HealthCare, while the company was presented with the Scrip Award for "Outsourcing deal of the year" for agreeing their contract with Sanofi back in 2011. John Watson, the Senior Vice President of the company, will talk about the secret of successful research and development using innovative approaches. And Prof. Dr Emanuele Gatti, member of the Management Board for the regions of Europe, Latin America, the Middle East and Africa at Fresenius Medical Care, will discuss at the conference how his company has been able to develop using vertical integration from a supplier of dialysis products to a broad-based renal health care company.
For more information about Rethinking Pharma Summit, please visit: http://bit.ly/pharmasummit
Diese Pressemitteilungen könnten Sie auch interessieren
Gemeinsam mit der AMSEL, Aktion Multiple Sklerose Erkrankter, Landesverband der DMSG in Baden-Württemberg, hat der DMSG-Bundesverband ein weiteres...
Die zunehmenden Antibiotikaresistenzen bei Bakterien sind ein ernstes Problem für die Gesundheit und das Gesundheitssystem, neue Antibiotika-Entwicklungen...
Es geht ein Ruck durch die deutsche Krankenhauslandschaft. Dies wurde auf dem diesjährigen Hessischen Krankenhaustag deutlich. In Hanau waren...